A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride
Accessinfo:eu-repo/semantics/openAccessAttribution 4.0 International (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
MetadataShow full item record
CitationKarayağmurlu, A., Karayağmurlu, E., Üstündağ, M. F., Yazla, E. (2018). A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride. Electronic Journal of General Medicine, 15(3).
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature. © 2018 by the authors; licensee Modestum Ltd., UK.